EGFR and lung carcinoma: Other genetic tests that can be performed and are not part of the routine molecular diagnostics of lung cancer include the MET gene amplification test, especially in patients with progression during EGFR TKI therapy in the absence of the Thr790Met resistance mutation in exon 20 of the EGFR gene.